Research and experimental development on natural sciences and engineering
PHARMASUM THERAPEUTICS AS
Revenue 2024
NOK 990,000
Operating profit
NOK −2.8m
Equity
NOK −26,000
Incorporated
2014
Share capital
NOK 323,000
Roles
Daglig lederAnders Kohler Fugelli
Regnskapsfører
Revisor
Styrets lederAnders Kohler Fugelli
StyremedlemØystein Soug
StyremedlemJohn Sigurd Mjøen Svendsen
StyremedlemTone Bjørnov
StyremedlemReijo Juhani Salonen
Auditor
Audit firm
REVICOM AS
REVICOM AS har 22 registrerte statsautoriserte revisorer.
The Brønnøysund registers name the audit firm, not which individual auditor signs the accounts.
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| JAKOB HATTELAND INVEST AS | 27.9% | 900039.000000 | 2025 |
| PHARMAPATENT AS | 8.0% | 258340.000000 | 2025 |
| FUGELLI INVEST AS | 8.0% | 257070.000000 | 2025 |
| INVEN2 AS | 3.2% | 103448.000000 | 2025 |
| ANDERS KOHLER FUGELLI | 3.0% | 96307.000000 | 2025 |
| GWM AS | 2.4% | 76930.000000 | 2025 |
| PHARMA HOLDINGS AS | 2.1% | 68142.000000 | 2025 |
| HEYERN AS | 2.1% | 67560.000000 | 2025 |
| BENT ERIKSEN AS | 2.0% | 63800.000000 | 2025 |
| TAJ HOLDING AS | 1.9% | 60346.000000 | 2025 |
| BENGT KENNETH HOLMGREN | 1.8% | 58333.000000 | 2025 |
| O2H VENTURE LTD | 1.3% | 41941.000000 | 2025 |
| MARY SYLVIA OLSEN | 1.3% | 41666.000000 | 2025 |
| PICASSO AS | 1.1% | 37099.000000 | 2025 |
| CARE HOLDING AS | 1.1% | 36044.000000 | 2025 |
| DREXCIYA AS | 1.1% | 34483.000000 | 2025 |
| ESBEN OMRE | 1.0% | 33333.000000 | 2025 |
| BERNT ROAR JANSRUD | 1.0% | 32000.000000 | 2025 |
| LUKAS I AS | 0.9% | 30000.000000 | 2025 |
| SYNOVIA AS | 0.8% | 24800.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.